Equipoise (boldenone undecylenate) appears to be comparable to nandrolone in its potency. It lacks nandrolone’s advantage of being metabolically deactivated by 5a -reductase. It is only slightly estrogenic, and only after conversion to estrogen. I cannot at the moment comment on whether the effect it does produce is owed to strong binding at the androgen receptor (AR) or to effectiveness in promoting non-AR-mediated mechanisms for growth.
I wouldn’t expect much results with less than 400 mg/of Equipoise per week. With that dose I would expect to see some noticeable but not dramatic results by the third week. Below 200 mg/week I would expect to see essentially nothing.
Boldenone undecylenate is the chemical name of active ingredient in Equipoise. Equipoise is a registered trademark of Wyeth Holdings Corporation in the United States and/or other countries.
About Bill Roberts
Bill Roberts+ received a bachelor degree in Microbiology and Cell Science and completed the educational and research requirements for a PhD in Medicinal Chemistry. His education was not specifically "geared" toward androgens other than expertise with pharmacological principles having broad applications. This has allowed Bill to provide unique insight into the field of anabolic pharmacology with knowledge of points which he would not have known otherwise.
More Posts (98)